Market-Share Surge Buried Under JLR Collapse and Margin Trap

On the headline, group revenue fell 8.2% YoY and net profit crashed 78.5% to a bare ₹859 Cr (0.9% NPM). But beneath that sits a sharp contrast: India Passenger Vehicles boomed 65% to ₹18,000 Cr and claimed #2 market position with 43% EV share, while JLR's profit halved to GBP 109M on wholesale decline of 10%. The real story, however, is margin compression — a 4.5% commodity hit in Q1 (with another 3% expected Q2) has gutted profitability faster than the 1% price increase management took can offset. Management's claim to 'neutralize via price and cost reduction' is already failing on the math.

India PV delivered ₹18,000 Cr revenue (up 65% YoY), but group consolidated revenue fell 8.2% YoY because JLR's revenue decline (down 10% wholesale on geopolitical disruption, Jaguar run-out, and China weakness) outweighs India's growth on a consolidated basis. More critically, profitability collapsed: India EBIT margin remained flat at 4% YoY despite 65% revenue growth (cost reductions 2% offset commodity 6%), while JLR's EBIT margin fell sharply to 2.8%. Consolidated EBIT margin compressed to just 2.4%, and net profit reached a bare ₹859 Cr (0.9% NPM) — a level that implies near-breakeven cash generation.

Management's defense is transparent: pricing power is constrained by competition. But that same competitive benchmarking is why the margin offset fails. Cost reduction of 2% YoY, even accelerated as promised, cannot bridge a 3.5% gap in Q1 and another 3% headwind in Q2. Management guided that Q2 margins would be 'flattish' vs. Q1 despite 3% additional commodity; that guidance, if met, proves the 'neutralize' thesis is folding.

Post-result price action: The stock fell 3.98% on day 1 (delivery 47.2%, institutional selling) and continued to fall 7.25% by day 3 — the market's own verdict: the miss held. There was no relief rally; the sell-off was decisive and sticky.

Valuation & drawdown context: Stock is at ₹321.3, down 23.32% from its all-time high of ₹419. It is now trading below its SMA20 (₹337), SMA50 (₹345.62), and SMA200 (₹355.63) — a clear downtrend. RSI at 39.8 is neutral (not oversold). The stock is at mid-range territory in its 52-week band (₹294.3–₹419), but the technical picture is weak. A deep drawdown can signal opportunity, but only if margin compression reverses — which the Q1 result suggests is not imminent.

Institutional flows: FII holdings declined 0.18pp QoQ (17.29% → 17.11%); DII holdings increased 0.19pp (17.04% → 17.23%). The pattern is slight institutional trim and retail/DII nibble — not capitulation, but cautious positioning. Promoter holdings held flat at 42.51%, with no material insider selling signal from recent bulk deal activity.

Reconciliation: The post-result sell-off and sustained downtrend align with the fundamental read: margin compression is a real and near-term problem, and management's 'neutralize via price' thesis is already failing. The FII trim reflects conviction, not panic. Street positioning is appropriately cautious.

Consolidated EBIT margin and JLR PBT are the twin tests. Q1 delivered 2.4% EBIT and ₹859 Cr net profit (0.9% NPM). If Q2 EBIT margin remains at or below 2.4% despite PLI/cost actions, the margin-recovery thesis is broken. Similarly, if JLR PBT remains sub-GBP 150M (i.e., below 43% of FY26 baseline), the structural JLR weakness is deepening, not reversing. Watch for India EBIT margin recovery (4% today) and JLR EBIT margin stabilization (2.8% today) as leading indicators of turnaround conviction.